Showing results (141-150 of 242) with videos related to
Sort By:
Pageof 25
Journal for Immunotherapy of Cancer|May 31, 2019
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinationsVidyalakshmi Chandramohan, Xuhui Bao, Xin Yu, et al.Molecular Cancer Therapeutics|October 17, 2006
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant gliomaJill A Maxwell, Stewart P Johnson, Jennifer A Quinn, et al.Journal of Toxicology and Environmental Health. Part B, Critical Reviews|May 26, 2009
Human exposure to selected animal neurocarcinogens: a biomarker-based assessment and implications for brain tumor epidemiologyDora Il'yasova, Bridget J McCarthy, Serap Erdal, et al.Oncotarget|October 22, 2013
The genetic landscape of anaplastic astrocytomaPatrick J Killela, Christopher J Pirozzi, Zachary J Reitman, et al.Molecular Cancer Therapeutics|September 16, 2004
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutationsManny D Bacolod, Stewart P Johnson, Anthony E Pegg, et al.Journal for Immunotherapy of Cancer|April 20, 2021
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanomaGeorgia M Beasley, Smita K Nair, Norma E Farrow, et al.Nuclear Medicine and Biology|May 15, 2007
Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspectsRoger E McLendon, Gamal Akabani, Henry S Friedman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa)Amy B Heimberger, Chris A Learn, Gary E Archer, et al.Molecular Cancer Therapeutics|September 20, 2005
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograftC Lynn Cheng, Stewart P Johnson, Stephen T Keir, et al.Neurosurgery|March 25, 2011
Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humansJohn H Sampson, Martin Brady, Raghu Raghavan, et al.Pageof 25